Incidence of opportunistic infections during ibrutinib treatment for B-cell malignancies

Kerry A. Rogers, Luay Mousa, Qiuhong Zhao, Seema A. Bhat, John C. Byrd, Zeinab El Boghdadly, Tomas Guerrero, Lauren B. Levine, Fabienne Lucas, Polina Shindiapina, Audrey M. Sigmund, Matthew Sullivan, Tracy E. Wiczer, Jennifer A. Woyach, Farrukh T. Awan

Research output: Contribution to journalLetter

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)2527-2530
Number of pages4
JournalLeukemia
Volume33
Issue number10
DOIs
StatePublished - Oct 1 2019
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Rogers, K. A., Mousa, L., Zhao, Q., Bhat, S. A., Byrd, J. C., El Boghdadly, Z., Guerrero, T., Levine, L. B., Lucas, F., Shindiapina, P., Sigmund, A. M., Sullivan, M., Wiczer, T. E., Woyach, J. A., & Awan, F. T. (2019). Incidence of opportunistic infections during ibrutinib treatment for B-cell malignancies. Leukemia, 33(10), 2527-2530. https://doi.org/10.1038/s41375-019-0481-1